Influenza A Virus H1N1 New Caledonia 20/99 IV 116
Shipping Info:
For estimated delivery dates, please contact us at [email protected]
Amount : | 50 µg |
Purification : | Greater than 90.0% as determined by ELISA analysis. |
Content : | The H1N1 A/New Caledonia/20/99 IVR solution contains STE, 0.1 % sodium azide (NaN3) and 0.005 % thimerosal. |
Storage condition : | A/New Caledonia/20/99 IVR although stable 4°C for 4 weeks, should be stored desiccated below -18°C. Please prevent freeze-thaw cycles. |
Source : Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/ New Caledonia/20/99 IVR 116. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient. H1N1 is a subtype specie of Influenza A virus. H1N1 Influenza Virus has mutated into various strains such as the Spanish Flustrain, mild humanflu strains, endemic pigstrains, and various strains found in birds. The Influenza A Virus is a globular particle about 100nm in diameter, sheathed in a lipid bilayer derived from the plasma membrane of its host. Studded in the lipid bilayer are two integral membrane proteins some 500 molecules of hemagglutinin ('H') and some 100 molecules of neuraminidase ('N'). Within the lipid bilayer are 3000 molecules of matrix protein and 8 pieces of RNA. Each of the 8 RNA molecules is associated with many copies of a nucleoprotein, several molecules of the three subunits of its RNA polymerase some 'non-structural' protein molecules of uncertain function.
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
There are currently no product reviews
|